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Background: Hepatitis B virus (HBV)-X protein(HBx) is a transactivator of host several cellular genes including
alpha-fetoprotein(AFP) and AFP receptor(AFPR) which contributes to HBV-associated tumor development. The
expression of AFP/AFPR are correlated with hepatocellular carcinoma(HCC)-initial cells. But the role of AFP and
AFPR in promoting occurrence of HBV-related HCC were still unclear.
Methods: A total of 71 clinical patients’ liver specimens, normal human liver cells L-02 and HCC cell lines, PLC/
PRF/5 were selected for analyzing the effects of HBx on expression of AFP, AFPR and Src. The expression of goal
proteins were detected by Immunohistochemical stained and Western blotting; HBx-expressed vectors were
constructed and transfected into L-02 cells, laser confocal microscopy was applied to observe expression and
location of AFP, AFPR and Src in the normal liver cells and HCC cells, soft agar colony formation assay was used
to observe colonies formed of the cells.
Results: We confirmed HBx gives preference to promote the expression of AFP and AFPR; HBx priors to up-regulate
the expression of AFPR and AFP in L-02 cells and in normal liver specimens; AFPR signal been able to stimulate Src
expression. The results also indicated that phosphatidylinositol 3-kinase(PI3K) inhibitors Ly294002 and GDC0941
effectively suppress AFPR mediated up-regulation expression of Src in AFPR positive HCC lines.
Conclusions: HBx priors to drive the expression of AFP and AFPR to promote expression of Src in normal liver cells and
hepatoma cells; AFP and AFPR maybe play pivotal role in HBV-related hepatocarcinogenesis; Targeting AFPR is an
available therapeutic strategy of HCC.
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Hepatocellular carcinoma(HCC) development closely as-
sociated with infected by hepatitis B virus(HBV). HBV-X
protein(HBx), a small regulatory protein of HBV that has
been require for contributing to the onset and progression
of HBV-related HCC [1-3]. However, the molecular mech-
anisms involved in HBx-mediated hepatocarcinogenesis
remain to be fully elucidated. HBx emerged transcriptional* Correspondence: mengsenli@163.com
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HBx does not directly bind to genomic DNA of host cells,
but has been shown to interact with components of basal
transcription machinery [7,8] and several transcription
factors, such as p53, HIF-1α and E4F1 [9-11]. However,
documents evidenced that the localization of HBx pre-
dominantly in the cytoplasm, HBx harbors a function to
activate signal transduction cascades, including phos-
phatidylinositol 3-kinase(PI3K)/protein kinase B(AKT)
[12,13] and mitogen-activated protein kinase(MAPK) [14].
Activation of these signal pathways may contribute to
HBx-mediated effects on driving malignant transform-
ation of liver cells.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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diagnosis, promote tumor cells proliferation effects of
AFP have been reported by several groups [15,16], fur-
thermore, data indicated that AFP play pivotal role in
the hepatocarcinogenesis [17]. Our investigations found
that these effects of AFP maybe mediated by AFP recep-
tors(AFPR) [18,19], cytoplasmic AFP activated PI3K/
AKT signal pathway to promote expression of some on-
cogenes and proliferation of HCC cells [16,20,21]. HBx
priors to induce expression of AFP and AFPR to activate
PI3K/AKT signal pathway in normal liver tissues and cell
lines [22]. Because HBx was a critical factor for HBV
driving development of HCC, HBx activates Wnt/β-ca-
tenin and Src kinase led to malignant transformation of
liver cells [23], and Src plays important role in HCC de-
velopment [24]. In this study, we discovered that HBx
priors to induce expression of AFP and AFPR in normal
liver tissues and liver cell lines via activating PI3K/AKT
signal, and AFP promoted expression of Src was medi-
ated by AFPR, AFPR signal possess a character to acti-
vate PI3K/AKT. Our results supported that AFP and
AFPR as potential stimulated factors for HBx inducing
hepatocarcinogenesis.Methods
Clinical specimens collected
Archived clinical specimens were originally collected
during hepatectomy of 71 patients at Hainan Provincial
People’s Hospital between October 2008 and September
2014. Of the 71 patients, 49 were male and 22 were fe-
male. The ages ranged between 22–76 years with an
average age of 49.8 years. All enrolled patients were
treated with radical surgery and received no other treat-
ments. HBV infection was diagnosed by a test of serum
hepatitis B surface antigen, and circulating AFP plasma
level was measured by enzyme-linked immunosorbent
assay. Clinical data were obtained by retrospective chart
review. Follow-up was available for all patients. A sec-
tion of liver tissue about 2.0 × 2.0 × 2.0 cm was obtained
from each patient immediately after the surgery. About
1.0 × 1.0 × 1.0 cm tissue samples were fixed in 10% for-
malin, embedded in paraffin, and routinely stained with
hematoxylin and eosin. Specimens were assessed blindly
and independently by two pathologists. In case of inter-
observer disagreement, final decisions were achieved by
general consensus. All selected patients were diagnosed
by histopathologic evaluation. About 1.0 × 1.0 × 1.0 cm
tissue specimens were stored in formalin and liquid ni-
trogen. The study protocol was approved by the Ethical
Committee of Hainan Provincial Peoples’ Hospital and
the Science Investigation Ethical Committee of Hainan
Medical College. Written informed consent was obtained
from all participants.Immunohistochemical stained
All of clinical patients’ liver tissues were performed by im-
munohistochemical staining. Following deparaffinization
and antigen retrieval, the slides were blocked with 3%
hydrogen peroxide for 10 minutes and then incubated with
mouse anti-AFP, AFP receptor(AFPR), or Src-directed anti-
bodies (Abcam Biotech Company, Cambridge, UK) at 4°C
overnight. After washing, sections were incubated with sec-
ondary goat anti-mouse antibodies (Merck-Calbiochem) at
room temperature for 60 minutes and then developed with
3,3-diaminobenzidine chromogen solution in 3,3-diamino-
benzidine buffer substrate(Merck Chemicals). Sections
were visualized with 3,3-diaminobenzidine and counter-
stained with hematoxylin. All sections were visualized by
microscope(Olympus).
Cell lines
Human normal liver cell lines, L-02 cell was purchased
from the Shanghai Institution of Cellular Biology, Sci-
ence Academy of China and were cultured in RPMI
1640 medium supplemented with 10% fetal calf serum.
The AFP-producing and HBV-infected cell line PLC/
PRF/5 was gift from the Department of Cell Biology,
Peking University Health Science Center and were
maintained in Dulbecco’s modified Eagle’s medium(D-
MEM) supplemented with 10% fetal calf serum. All cell
lines were cultured at 37°C in a humidified atmosphere
containing 5% CO2.
Generation of HBx-expressing constructs and transfects
Construction of the HBx-expressing construct (pcDNA3.1-
HBx) and the primer used for HBx gene amplification have
been previously described [22]. Lipofectamine® 2000(Beyo-
time Biotechological Corp, Haimen, Jaingsu, China) was
used to promote pcDNA3.1-HBx vectors transfected into
L-02 cells. Stably transfected L-02 cells were screened
using G418 (Cat No. 30-234-CR, MediatechInc, Manassas,
USA) and named L-02-X.
Western blotting analysis
Western blotting was employed to assess the protein levels
of AFP, AFPR and Src. Twelve clinical patients’ specimens
that were randomly selected for detecting and these
protein expressed in cell lines as described previously
[21,22]. The cells were co-treated Ly294002 or GDC-
0941(MedChem) with AFP(Sigma), and the expression of
Src, pAKT(Ser473) were detected by Western blotting.
Localization of proteins were observed by laser confocal
microscopy
The staining procedure for laser confocal microscopy
observing has been previously described [22]. Briefly,
cells were fixed in 4% paraformaldehyde and incubated
with mouse anti-human AFPR, AFP and Src antibody
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secondary anti-mouse immunoglobulin G was added
and incubated for 2 hours, followed by the addition of
100 μL DAPI (1 μg/mL) and 30 minutes of incubation.
Cells were visualized with the Leica TCS-NT SP2 laser
confocal microscopy (Leica Camera).
Soft agar colony formation assay
Soft agar formation assays were performed to compare
the clonogenic potential of L-02 and L-02-X cells in
semisolid medium. Briefly, 5000 cells of L-02 or L-02-X
were mixed with 0.5% soft agar and plated on a layer of
0.8% of bottom agar in 6-well plates. 2 mL of complete
medium was added on the top of agar. Cells were fed
twice a week, and the plates were incubated for 14 or
21 days at 37°C with 5% CO2. Colonies were photo-
graphed and counted with a Nikon inverted microsco-
pe(Nikon Corp., Tokyo, Japan).
Statistical analysis
The results of multiple observations were presented as
the mean ± SD of at least three separate experiments.
Statistical significance was determined using x2 and the
student’s t test (SPSS 11.5 software).
Results
Expression of AFP, AFPR and Src were stimulated during
the development of HBV-related HCC
We studied the expression of AFP, AFPR and Src in liver
tissue samples from 71 patients by immunohistochemical
staining and Western blotting. The results indicated that
AFP expressed in HBV-infected tissues, HBV positive cir-
rhosis liver tissues and HBV-related HCC tissues was
42.8%, 70.6% and 86.4% respectively; AFPR expressed in
these tissues was 50.0%, 75.5% and 90.9% respectively; Src
expressed in these tissues was 28.6%, 52.9% and 63.6% re-
spectively; The levels of AFPR was significantly higher in
AFP+/HBV+ liver tissues than in AFP-/HBV+ or AFP-/
HBV- liver tissues (Additional file 1). Statistical analysis
indicated that expression of AFP and AFPR were signifi-
cantly elevated than the expression of Src during the pro-
gression of HBV-infected liver tissues to HBV-related
HCC. The expression of Src also progressively elevated in
HBV infected liver tissues→ cirrhosis liver tissues→
HBV-related HCC tissues (Additional file 1). Immunohis-
tochemical staining indicated that AFPR located in the
membrane of liver tissue cells, and much higher level in
HCC tissues than in other liver tissues, expression of
AFPR progressively elevation from normal liver tissue to
HBV-infected tissue to cirrhotic tissue to HCC tissues
(Figure 1A). Location of AFP was in cytoplasm and the lo-
cation of Src both in cytoplasm and cytoblast of the cells,
these protein expressed much higher level in HCC tissues
than in other liver tissues (Figure 1A); Western blottingdetection showed that expression of AFPR emerged in
HBV-infected liver tissues, but Src and AFP expression
were limited to cirrhotic and HCC tissues (Figure 1B);
Moreover, the expression of AFPR and AFP significantly
higher than Src in hepatitis tissues (Additional file 1 and
Figure 1B). We confirmed that expression of AFPR and
AFP were positively associated with liver tissues which in-
fected with HBV and progressed of HBV-related HCC.
HBx-expressed vectors induce expression of AFP and
AFPR prior to induce expression of Src in human normal
liver cells in vitro
We transfected a vector that expressing HBV protein
HBx, pcDNA3.1-HBx, into human liver cell lines L-02
in vitro, Western blotting analysis showed that HBx
expressed in L-02 cells (Figure 2A) . The pcDNA3.1-HBx-
mediated induction of HBx expression in L-02 cells was
evident at 3 days after transfection and remained elevated
between 7 and 28 days after transfection (Figure 2A). In
order to measure the impact of pcDNA3.1-HBx on the
expression of AFPR, AFP and Src, L-02 cells were trans-
fected with pcDNA3.1-HBx vectors and the aim proteins
were detected by Western blotting. The results indicated
that expression of AFPR and AFP were emerged after
transfected with pcDNA3.1-HBx for 7 days and persisted
increasing after 28 days (Figure 2B). But expression of Src
start emerged after transfection for 14 days and increased
after 21 days to 28 days (Figure 2B).
Laser confocal microscopy observed confirmed that HBx
promoted expression of AFPR, AFP and Src in human
normal liver cell line
While human normal liver cell line, L-02 cells were
transfected with pcDNA3.1-HBx vectors, to evaluate the
effects of pcDNA3.1-HBx on expression and localization
of AFPR and AFP by laser confocal microscopy. The re-
sults indicated that AFPR and AFP start emerged in
14 days and significantly augmented after transfection
for 28 days, AFPR located in the membrane of the cells
(Figure 3A), however, AFP located in the cytoplasm of
the cells (Figure 3B). Src played critical role in HBV-
related HCC development [25,26]. In this investigation,
furthermore, we explored the influence of HBx on the
expression of Src. The results indicated that while L-02
cells were transfected with pcDNA3.1-HBx vectors
in vitro, the expression of Src was stimulated after trans-
fection for 14 days, and significantly elevated for 28 days.
Observed by laser confocal microscopy also displayed
that the location of Src not only in the cytoplasm but
also in the cytoblast (Figure 3C), this appearance coin-
cide to the location of Src in clinical HCC tissues that
analyzed by immunohistochemical stained. These results
confirmed that HBx been able to induce expression of
AFPR, AFP and Src in human normal liver cell line. The
Figure 1 Expression of AFPR, AFP and Src in clinical patients liver tissues. A, Clinical liver tissues sample were collected after surgical hepatectomy, the
expression of AFPR, AFP and Src in clinical patients liver tissues were detected by immunohistochemical assay. B, Expression of AFPR, AFP and Src in
these tissues were detected by Western blotting, low column images represented the protein densitometry value contrast to internal control β-actin
ratio. *P < 0.05 vs normal liver tissue groups; **P <0.01 vs normal liver tissue groups and hepatitis tissue groups. We carried out at last three reduplicate
experiments. HE stained: hematoxylin-eosin stained; IH stained: immunohistochemical stained.
Figure 2 Effects of HBx on the expression of AFPR, AFP and Src in human normal liver cell line, L-02 cells. A, L-02 cells were transfected with
pcDNA3.1-HBx vector for 72 hours, expression of HBx in L-02 cells were evidenced by Western blotting, human hepatoma cell line, PLC/PRF/5 cells
were used as a positive control. B, L-02 cells were transfected with pcDNA3.1-HBx vectors for 0, 7, 14, 21 or 28 days respectively, expression of
AFPR, AFP and Src in L-02 cells were evidenced by Western blotting, right column images represented the protein densitometry value contrast to
internal control β-actin ratio. **P <0.01 vs control and 0 day treated groups. The images were representation of three reduplicate experiments.
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Figure 3 HBx induced expression of AFPR, AFP and Src in L-02 cells. L-02 cells were transfected with pcDNA3.1-HBx vectors for 0, 14, or 28 days
respectively, expression of AFPR, AFP and Src in L-02 cells were observed by laser confocal microscopy. A, Expression of AFPR in L-02 cells were
stained by FITC; B, Expression of AFP in L-02 cells were stained by TRITC; C, Expression of Src in L-02 cells were stained by TRITC. The images were
representation of three reduplicate experiments.
Zhu et al. BMC Cancer  (2015) 15:362 Page 5 of 9results proved that HBx driven hepatocarcinogenesis
maybe involved in promoting expression of AFPR, AFP
and Src.
AFPR signal activated PI3K/AKT to mediate AFP induced
Src expression
L-02 cells were stable transfected with pcDNA3.1-HBx,
the cells were screened by G418 named L-02-X cells.
Western blotting analytical results indicated that stable
expression of AFPR in L-02-X cells, but AFPR could not
reveal in L-02 cells. HBV positive human HCC cell line,
PLC/PRF/5 also emerged expression of AFPR (Figure 4A).
When L-02, L-02-X and PLC/PRF/5 cells were treated
with AFP for 24 hours, the expression of Src and phos-
phorylated AKT(Ser473) were stimulated in L-02-X cells
and PLC/PRF/5 cells, but the effects absent emerge in L-
02 cells. In order to investigate whether AFPR signal beencapable of activating PI3K/AKT signal pathway, PI3K spe-
cific inhibitor, Ly294002 and GDC0941 were co-treated
with AFP, the results indicated that Ly294002 and
GDC0941 had an antagonistic role in AFP inducing
expression of Src and phosphorylated AKT(Ser473) in L-
02-X cells and PLC/PRF/5 cells (Figure 4B and C). These
results proved that AFPR signal was able to activate PI3K/
AKT signal pathway to mediate AFP induced expression
of Src in L-02-X cells and hepatoma PLC/PRF/5 cells.
Colony formation assay confirmed that HBx induced
expression of AFPR, AFP and Src to promote malignant
phenotype of liver cells
Expression of Src involve in the tumorigenesis. In the
present study, we have found that HBx induced expres-
sion of AFPR and AFP prior to induce expression of Src
in human normal liver cell line L-02. L-02 cells and
Figure 4 Influences of AFP on the expression of Src and pAKT(Ser473) in L-02 cells, L-02-X(stable transfected with pcDNA3.1-HBx) cells and PLC/PRF/5
cells. A, Expression of AFPR in L-02, L-02-X and PLC/PRF/5 cells were analyzed by Western blotting. B, L-02, L-02-X or PLC/PRF/5 cells were treated with
AFP(20 mg/L), Ly294002(20 μM) or co-treated with AFP(20 mg/L) and Ly294002(20 μM) for 24 hours respectively, expression of Src and pAKT(Ser473) in
these cells were analyzed by Western blotting, right column images represented the protein densitometry value compare with internal control β-actin
or total AKT ratio. *P < 0.05 vs treated with AFP, Ly294002 or co-treated with AFP and Ly294002 groups; **P <0.01 vs untreated, treated with Ly294002
or co-treated with AFP and Ly294002 groups. C, L-02, L-02-X or PLC/PRF/5 cells were treated with AFP(20 mg/L), GDC0941(10 μM) or co-treated with
AFP(20 mg/L) and GDC0941(10 μM) for 24 hours respectively, expression of Src and pAKT(Ser473) in these cells were analyzed by Western blotting,
right column images represented the protein densitometry value compare with internal control β-actin or total AKT ratio. *P < 0.05 vs treated with AFP,
GDC0941 or co-treated with AFP and GDC0941 groups; **P <0.01 vs untreated, treated with GDC0941 or co-treated with AFP and GDC0941 groups.
The images were representation of three reduplicate experiments.
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tured in soft agar. The results indicated that L-02 or L-
02-X cells colonigenesis in the soft agar. The number of
colonies from 6 randomly selected microscopic fields
was counted and an average colony number for each
group was shown in Figure 5. L-02-X cells colonies
number and growth significantly more than L-02 cells.
Overall, these results suggest that HBx promoted expres-
sion of AFP, AFPR and Src was able to cause a more ma-
lignant phenotype in L-02 cells.
Discussions
HBx proteins play important roles in the development of
HBV-related HCC through the activation of growth sig-
nal pathways and the inactivation of tumor suppressive
pathways, such as transcripted activity of p53 [9,27]. In
this study, we found that overexpression of AFP, AFPR
and Src in cirrhosis and HBV-related HCC tissue sam-
ples, and showed that expression of AFPR and AFP prior
to expression of Src during the progress of HBV-related
hepatocarcinogenesis. These results implied that HBx is
involved in AFPR and AFP overexpression during HBVinfection. HBx inactivation transcripted activity of p53
to alleviate p53 mediated repression of AFP expression
[9], HBx also stimulated expression of Src via activating
PI3K signal pathway [28], whereas, in this study, we des-
pite found that HBx upregulated expression of AFPR,
but the role played of HBx in regulating expression of
AFPR is still unclear. Recently, we found that HBx pro-
moted AFPR expression maybe involve in activating
PI3K/AKT signal [22]. These results clued to that activa-
tion of PI3K/AKT signal was critical procedure for HBx
driving malignant transformation of liver cells.
Recently, documents reported that AFP played pivotal
role in HCC development and malignant behavior of
liver cells [29-31], cytoplasmic AFP activated PI3K/AKT
signal to stimulate expression of Ras, CXCR4 and Src
through inhibiting activity of PTEN [16,21], AFP also
inhibited the PI3K/AKT pathway through promoting
ubiquitination of PTEN to stimulated malignant pheno-
type of HCC cells [32]. HBV infection caused malignant
transformation of liver, during this course, AFP gene was
activated in liver cells, so AFP was used as a tumor
marker for early warning origination of HCC in clinical
Figure 5 Overexpression of HBx affects colony formation of L-02 and L-02-X in soft agar. 5×103/ml L-02 or L-02-X cells were cultured in soft agar
for 14 or 21 days, colony formation of the cells were observed by light microscopy(×40); The low column image indicated the statistical difference
of the cellular clone numbers. The images were a representation of three independent experimentations.
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proliferation of HCC cells was mediated by AFPR, AFPR
was identified as G-protein combined receptor, AFPR
signal mediated cAMP and [Ca2+]i transduction of re-
ceptor signal to promoted expression of N-Ras and c-
myc [19], these results implied that AFPR signal was also
a critical factor for HCC development. In this investiga-
tion, the results indicated that human normal liver cells,
L-02 were transfected with HBx-expressed vectors been
able to stimulate expression of AFPR priors to the ex-
pression of AFP and Src, the results implicated that AFP
played important role in inducing malignant transform-
ation of liver cells and enhancing HCC cells malignant
behavior was mediated by AFPR.
Activation of Src foreshowed the occurrence of cancer.
HBx induced HCC development involve in activation of
Src [33,34]. In the present study, clinical data displayed
that during progression of HCC, elevated expression of
Src in liver cells were closely associated with infection of
HBV, these results implied that HBx stimulated expression
of Src plays an important role in HBV promoting develop-
ment of HCC. HBx enhanced proliferation and anti-
apoptosis and autophagy through activating transductionof PI3K/AKT signal pathway [13,35], and PTEN specific
suppression of HBx-mediated cell survival through inhibit-
ing PI3K pathway in human normal liver cells, Chang liver
[36]. In this investigation, our results indicated that HBx
induced expression of AFPR and location in membrane of
L-02-X cells, the expression of AFPR also existed in HBV
positive human liver cancer cells PLC/PRF/5. While these
cells were treated with AFP, the expression of Src was
stimulated, and PI3K specific inhibitor Ly294002 and
GDC0941 were capable of withhold the role of AFP.
These effects implicated that AFP promoted expression of
Src and phosphorylation of AKT(Ser473) in AFPR positive
cell lines was mediated by AFPR, it also proved that AFPR
possessed a characteristic to activate transduction of PI3K/
AKT signal pathway. The present study is the first time
that discovered AFPR signal activated PI3K/AKT through
signal cross-talk or AFPR maybe plays a role model of
tyrosine protein kinase receptor. Recently, we found that
HBx driven expression of AFP to activate transduction of
PI3K/mTOR signal, stimulated expression of Src and
CXCR4 in human normal liver cells [37], AFP also played
role in promoting migration of HCC cells [38]. In this in-
vestigation, soft agar cultured experiment demonstrated
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line was able to promote colonigenesis and growth in soft
agar, implied HBx driven malignant phenotype of liver
cells involve in promoting expression of Src. Notwith-
standing, our previously study results have confirmed that
cytoplasmic AFP promoted proliferation and anti-
apoptosis of HCC cells through activating growth signal
and inhibiting apoptotic signal [21,39,40], but in this study,
we found that HBx induced expression of AFPR and AFP
to promote expression of Src in normal liver cells, activa-
tion of AFPR signal was a critical factor for HBx driving
HCC occurrence. AFPR maybe is applied as a novel bio-
target for therapeutics of HCC.
Conclusions
Taken together, our findings are the first time to report
HBx induced expression of AFPR, and AFPR signal pos-
sessed an identity to activate PI3K/AKT signal to pro-
mote expression of Src. AFPR plays important role in
HBx driving hepatocarcinogenesis. Targeting AFPR to
suppress PI3K/AKT signal is an available strategy of
HCC therapeutic.
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